Clearview Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$821K Sell
3,595
-159
-4% -$36.2K 0.52% 43
2025
Q3
$869K Sell
3,754
-93
-2% -$18.9K 0.56% 41
2025
Q2
$714K Sell
3,847
-9
-0.2% -$1.67K 0.5% 43
2025
Q1
$808K Sell
3,856
-128
-3% -$24.9K 0.6% 34
2024
Q4
$708K Sell
3,984
-34
-0.8% -$6.25K 0.54% 40
2024
Q3
$794K Sell
4,018
-106
-3% -$19.8K 0.61% 37
2024
Q2
$707K Sell
4,124
-177
-4% -$29.3K 0.62% 36
2024
Q1
$783K Sell
4,301
-129
-3% -$22.2K 0.8% 30
2023
Q4
$687K Buy
4,430
+18
+0.4% +$2.62K 0.8% 44
2023
Q3
$658K Sell
4,412
-351
-7% -$51.5K 0.81% 46
2023
Q2
$642K Sell
4,763
-54
-1% -$7.92K 0.65% 45
2023
Q1
$768K Sell
4,817
-1,833
-28% -$280K 0.78% 32
2022
Q4
$1.07M Buy
6,650
+27
+0.4% +$4.14K 0.83% 26
2022
Q3
$889K Buy
6,623
+204
+3% +$29.3K 0.7% 24
2022
Q2
$983K Buy
6,419
+144
+2% +$22K 0.74% 23
2022
Q1
$1.02M Sell
6,275
-148
-2% -$21.5K 0.67% 26
2021
Q4
$870K Buy
6,423
+293
+5% +$34.6K 0.53% 44
2021
Q3
$661K Sell
6,130
-353
-5% -$40.3K 0.42% 53
2021
Q2
$730K Buy
6,483
+381
+6% +$42.9K 0.45% 49
2021
Q1
$660K Buy
6,102
+608
+11% +$65K 0.43% 53
2020
Q4
$589K Buy
+5,494
New +$528K 0.4% 56

Other funds holding ABBV